A majority of affected patients have a near complete loss of ADA function resulting in a profound depletion of T-cells, B-cells, and NK-cells; however about 20% of cases have a less complete deficiency of ADA and can present with delayed onset of combined immunodeficiency (CID) [1, 3]. This evidence concerns the gene ADA and combined immunodeficiency.